Skip to content

Mindfulness Meditation in Chronic Stress

Mindfulness Meditation in Chronic Stress: Measures of Adherence, Ability & Stress

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01386060
Enrollment
134
Registered
2011-06-30
Start date
2011-06-30
Completion date
2017-06-30
Last updated
2018-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

Stress, Mindfulness, Meditation

Brief summary

The study purpose is to evaluate efficacy of a mindfulness training intervention and learn about cognitive and physiological markers of stress.

Detailed description

Subjects will first undergo a phone screening, and if eligible, they will complete three study visits at Week 1, Week 8, and Week 15. The study visits involve at-home surveys, voice recordings, physical measures (height, weight, waist-to-hip ratio, and blood pressure), EEG recordings (including recordings of electrodermal activity and heart rate variability), computer tasks, in-lab saliva collection, overnight urine collection, 2-day saliva collection at bed waking, 30 minutes post-waking, afternoon, and bedtime, and a small handheld device that randomly administers eight short assessments in the subjects' natural environment. Subjects will be randomized to receive a 6-week mindfulness meditation course either between the first and second study visits or between the second and third study visits. Participants who receive training during the first and second visits will continue meditating until the third visit. The one-on-one instruction occurs once a week for 1 ½ hours, and participants are asked to listen to guided meditations and do other mindfulness-based tasks on a daily basis between sessions.

Interventions

One-on-one mindfulness meditation training, 6 weeks, 1 1/2 hour training once per week, 30-45 min at-home practice per day.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 50-85 * Good General Health * Experiencing Stress * No current meditation practice * English speaking

Exclusion criteria

* Cognitive Impairment * Neurological Disease * Major Untreated Depression

Design outcomes

Primary

MeasureTime frameDescription
Changes in Physiological Markers of StressBaseline (Week 1) and Visit 2 (Week 8)Measure changes in blood pressure, heart rate, heart rate variability, neurological reaction time to visual stimuli, urine, saliva, waist-to-hip ratio, weight, and electrodermal response.

Secondary

MeasureTime frameDescription
Cognitive ChangesBaseline (Week 1) and Visit 2 (Week 8)In-lab cognitive tests measure attention and memory.
Changes in self-reported measures of stressBaseline (Week 1) and Visit 2 (Week 8)A series of questionnaires measure different facets of perceived quality of life and stress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026